RSS Feeds
Search

Companies

Cellerix S.L.

Out-licensing

Phase II Clinical Development of Cx501: Chimeric Skin for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB) More
Phase II Clinical Development of Cx601 for the Treatment of Fistulas: Expanded Allogeneic Adipose Derived Stem Cells for Local Delivery More
Phase III Clinical Development of Cx 401 for the Treatment of Complex Perianal Fistulas More
Preclinical Development of Cx611 for the Treatment of Autoimmune and Inflammatory Diseases: Expanded Allogeneic Adipose Derived Stem Cells for Local Delivery More

Contact details

Contact Cellerix

Contact directly

Full contact list

Head office

Cellerix S.L.
Calle Marconi, 1 Parque Tecnológico de Madrid
Tres Cantos
28760
Spain

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us